| ADNRX | VMGIX | ADNRX / VMGIX | |
| Total Expense Ratio | 1.05 | 0.19 | 553% |
| Annual Report Gross Expense Ratio | 1.18 | 0.19 | 621% |
| Fund Existence | 6 years | 20 years | - |
| Gain YTD | -4.290 | 4.706 | -91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 138M | 34.8B | 0% |
| Annual Yield % from dividends | 0.00 | 0.47 | - |
| Returns for 1 year | -3.79 | -0.25 | 1,518% |
| Returns for 3 years | 50.26 | 38.68 | 130% |
| Returns for 5 years | -54.29 | 21.91 | -248% |
| Returns for 10 years | N/A | 175.74 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BGETX | 14.23 | 0.17 | +1.20% |
| Baillie Gifford International Growth 2 | |||
| DOMYX | 12.47 | 0.12 | +0.97% |
| Domini Impact International Equity Y | |||
| FSOSX | 15.61 | N/A | N/A |
| Fidelity Series Overseas | |||
| WFSTX | 10.53 | N/A | N/A |
| Allspring Innovation Fund - Class A | |||
| SBHSX | 15.67 | N/A | N/A |
| Segall Bryant & Hamill Intl Sm Cp Ret | |||